Matthew Campobasso - 27 Nov 2023 Form 3 Insider Report for Enfusion, Inc.

Role
General Counsel
Signature
/s/ Matthew Campobasso
Issuer symbol
N/A
Transactions as of
27 Nov 2023
Net transactions value
$0
Form type
3
Filing time
29 Nov 2023, 19:03:09 UTC
Next filing
10 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENFN Class A Common Stock 31,913 27 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 24,779 restricted stock units awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units vest as follows: 2,265 and 2,264 on each of October 20, 2024 and 2025, respectively; 5,545 and 5,544 on each of June 15, 2024 and 2025, respectively; 2,743, 2,743 and 2,742 on each of January 5, 2024, 2025 and 2026, respectively; and 311, 311 and 311 on each of February 28, 2024, 2025 and 2026, respectively.

Remarks:

Exhibit 24 - Power of Attorney